Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer | 溶瘤病毒治療在三陰性乳腺癌患者中產生了可喜的結果
NEWS RELEASE 9-FEB-2023 In a Moffitt phase 2 trial, talimogene laherparepvec plus neoadjuvant chemotherapy provided strong responses and immune cell activation Peer-Reviewed Publication …